"J&J Accuses Big Health Insurer of Helping Drain Its Drug Copay Funds; Pharmaceutical Company Claims Cigna Units Worked With SaveOn and Caused It to Pay More Than $100 Million in Copay Assistance Than It Would Have Otherwise" - WSJ
"J&J Accuses Big Health Insurer of Helping Drain Its Drug Copay Funds; Pharmaceutical Company Claims Cigna Units Worked With SaveOn and Caused It to Pay More Than $100 Million in Copay Assistance Than It Would Have Otherwise" - WSJ
"強生指控大型健康保險公司幫助耗盡其藥品共付基金；藥品公司聲稱Cigna單位與SaveOn合作，導致其支付的共付援助超過10000萬美元，遠超原本應支付的金額" - 華爾街日報
Johnson & Johnson has sued divisions of health insurer Cigna, accusing them of working with a drug-benefit middleman to drain J&J financial-assistance funds earmarked for patients taking some of its pricier drugs.
強生公司已起訴健康保險公司信諾的部門，指控他們與藥品福利中間人合作，耗盡強生專門爲服用某些價格較高藥物的患者提供的經濟援助資金。
The move by J&J widens litigation the healthcare giant initiated in 2022 against a middleman, SaveOnSP LLC, and is a new flare-up of long-running tension over drug prices among manufacturers, insurers, pharmacy-benefit managers and other middlemen in recent years.
強生的舉動擴大了這家醫療巨頭於2022年對中間商SaveOnSP LLC提起的訴訟，也是近年來製造商、保險公司、藥房福利經理和其他中間商之間在藥品價格問題上長期緊張局勢的新一輪爆發。
資訊熱榜
更新時間